| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |